Liu L S, Spelleken M, Röhrig K, Hauner H, Eckel J
Molecular Cardiology, Diabetes Research Institute, Düsseldorf, Germany.
Diabetes. 1998 Apr;47(4):515-22. doi: 10.2337/diabetes.47.4.515.
Tumor necrosis factor (TNF)-alpha is postulated to play a major role in the pathogenesis of obesity-linked insulin resistance, probably resulting from an interaction with insulin signaling pathways. This cross talk has now been investigated in human adipocytes at the level of phosphatidylinositol (PI) 3-kinase, and the TNF receptors (TNFRs) mediating these processes have been identified. Equilibrium binding studies using human adipocytes from mammary tissue indicated the presence of two populations of TNFR with apparent affinity constants of 13 pmol/l and 1.6 nmol/l, respectively. Interaction of TNF-alpha with insulin signaling was determined by quantification of insulin receptor substrate (IRS)-1-associated PI 3-kinase activity. Under control conditions, PI 3-kinase was activated about 10-fold in response to insulin (10[-7] mol/l, 5 min). Preincubation of adipocytes with 5 nmol/l TNF-alpha for 15 min resulted in a 60-70% reduction of insulin action, reaching a stable inhibition (40%) after longer incubation with the cytokine. The inhibitory action of TNF-alpha was dose-dependent, already detectable at 10 pmol/l, and was correlated to inhibition of tyrosine phosphorylation of IRS-1 with an unaltered autophosphorylation of the insulin receptor beta-subunit. The modulation of insulin signaling by TNF-alpha was found to be paralleled by a comparable inhibition of insulin-stimulated glucose transport. An agonistic TNFR1 antibody completely mimicked the inhibitory action of TNF-alpha on insulin signaling, whereas at 100 pmol/l TNF-alpha, a nonagonistic p80 TNFR antibody, was shown to ameliorate the inhibitory action of the cytokine. These findings indicate that in human adipocytes, low concentrations of TNF-alpha induce a rapid inhibition of insulin signaling at the level of PI 3-kinase. We suggest that under these conditions, the p80 TNFR is essential for initiating the intracellular cross talk that involves signaling by the p60 TNFR.
肿瘤坏死因子(TNF)-α被认为在肥胖相关胰岛素抵抗的发病机制中起主要作用,这可能是由于其与胰岛素信号通路相互作用所致。目前已在人脂肪细胞中从磷脂酰肌醇(PI)3激酶水平对这种相互作用进行了研究,并确定了介导这些过程的TNF受体(TNFRs)。使用来自乳腺组织的人脂肪细胞进行的平衡结合研究表明存在两种TNFR群体,其表观亲和常数分别为13 pmol/l和1.6 nmol/l。通过定量胰岛素受体底物(IRS)-1相关的PI 3激酶活性来确定TNF-α与胰岛素信号的相互作用。在对照条件下,PI 3激酶在胰岛素(10[-7] mol/l,5分钟)刺激下被激活约10倍。脂肪细胞与5 nmol/l TNF-α预孵育15分钟导致胰岛素作用降低60-70%,与细胞因子孵育更长时间后达到稳定抑制(40%)。TNF-α的抑制作用呈剂量依赖性,在10 pmol/l时即可检测到,并且与IRS-1酪氨酸磷酸化的抑制相关,而胰岛素受体β亚基的自身磷酸化未改变。发现TNF-α对胰岛素信号的调节与胰岛素刺激的葡萄糖转运的类似抑制平行。一种激动性TNFR1抗体完全模拟了TNF-α对胰岛素信号的抑制作用,而在100 pmol/l TNF-α时,一种非激动性p80 TNFR抗体被证明可改善细胞因子的抑制作用。这些发现表明,在人脂肪细胞中,低浓度的TNF-α在PI 3激酶水平诱导胰岛素信号的快速抑制。我们认为在这些条件下,p80 TNFR对于启动涉及p60 TNFR信号传导的细胞内相互作用至关重要。